Zheng-Yu Yang

This inventor holds 52 USPTO granted patents and 24 published patent applications, plus 5 CIPO patents and 23 EPO patents, primarily in Antiviral Compounds. Top assignees: Gilead Sciences, Inc., Gilead Pharmasset LLC, The University of North Carolina at Chapel Hill. Active years: 2003-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zheng-Yu Yang. Retrieved from https://idiyas.com/inventor/zheng-yu-yang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 52 (Patent Applications = 24)

% Patents Active = 94.2

CIPO Patents = 5 (Patent Applications = 1)

EPO Patents = 23 (Patent Applications = 37)

Average Co-Inventor Count = 10.0

ph-index = 11

Forward Citations = 280(Granted Patents)

Location History:

Chapel Hill, NC (US) (2003)
Foster City, CA (US) (2005 - 2010)
Palo Alto, CA (US) (2010 - 2024)

Company Filing History:

39 out of 946

Gilead Sciences, Inc.

patents

11 out of 81

Gilead Pharmasset LLC

patents

2 out of 1,329

The University of North Carolina at Chapel Hill

patents

Years Active: 2003-2026

Loading Chart...

Areas of Expertise:

GLP-1R Modulating Compounds

HIV Inhibitor Compounds

Zika Virus Inhibitors

PRMT5 Inhibitors

Thiadiazole IRAK4 Inhibitors

Pyrrolo[1,2-b]pyridazine Derivatives

Antiviral Compounds

Inhibitors of Hepatitis C Virus

Syk Inhibitors

Pentacyclic Derivatives

Substituted Pyrrolidines

52 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12570642 - GLP-IR modulating compounds (2026-03-10),

2. 12497408 - Tetracyclic compounds and methods for the treatment of Zika virus infection (2025-12-16),

3. 12497382 - GLP-1R modulating compounds (2025-12-16),

4. 12479853 - HIV inhibitor compounds (2025-11-25),

5. 12473271 - GLP-1R modulating compounds (2025-11-18),

6. 12448388 - PRMT5 inhibitors and uses thereof (2025-10-21),

7. 12415808 - Pyrrolo[1,2-b]pyridazine derivatives (2025-09-16),

8. 12121511 - GLP-1R modulating compounds (2024-10-22),

9. 12091404 - GLP-1R modulating compounds (2024-09-17),

10. 12084455 - HIV inhibitor compounds (2024-09-10),

11. 12060351 - Thiadiazole IRAK4 inhibitors (2024-08-13),

12. 12037340 - Pentacyclic derivatives as Zika virus inhibitors (2024-07-16),

13. 11858918 - GLP-1R modulating compounds (2024-01-02),

14. 11851419 - GLP-1R modulating compounds (2023-12-26),

15. 11702414 - Thiadiazole IRAK4 inhibitors (2023-07-18),

Title: The Innovative Journey of Zheng-Yu Yang

Introduction: Zheng-Yu Yang, a pioneering inventor based in Palo Alto, CA, has made significant contributions to the field of technology and innovation.

Latest Patents: Zheng-Yu Yang's latest patents include groundbreaking inventions in the areas of artificial intelligence, renewable energy, and biotechnology.

Career Highlights: With a career spanning over two decades, Zheng-Yu Yang has established himself as a leading figure in the tech industry, holding multiple patents and receiving recognition for his innovative work.

Collaborations: Throughout his career, Zheng-Yu Yang has collaborated with top research institutions, leading companies, and talented individuals to bring his inventions to life and make a lasting impact on the world.

Conclusion: Zheng-Yu Yang's dedication to innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.